
Xeris Biopharma Holdings, Inc. Share Price
XERS$7.76
-$0.09 (-1.15%) Last updated on 09 Sep, 2025 | 01:29 ISTXeris Biopharma Holdings, Inc. Stock Performance
Open $7.81 | Prev. Close $7.85 | Circuit Range N/A |
Day Range $7.76 - $7.92 | Year Range $2.51 - $8.02 | Volume 99,576 |
Average Traded $7.83 |
Xeris Biopharma Holdings, Inc. Share Price Chart
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
08-Sep-25 | $7.81 | $7.76 | +0.00% |
08-Sep-25 | $7.81 | $7.76 | -1.33% |
05-Sep-25 | $7.90 | $7.87 | -0.13% |
04-Sep-25 | $7.85 | $7.88 | +0.51% |
03-Sep-25 | $7.86 | $7.84 | -1.01% |
02-Sep-25 | $7.77 | $7.92 | +1.28% |
29-Aug-25 | $7.92 | $7.82 | -0.89% |